10 Things You Should Know About Medicare Part D Plans
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Prime Big Deal Days · Oct 6–7Offer from Amazon

Get smart everyday buys delivered free — and shop member deals

  • Fast, free delivery on millions of items
  • Access to Prime Big Deal Days deals on October 6–7
  • Prime Video, Amazon Music and more included
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Kiplinger’s report urges Medicare Part D enrollees to compare plans during the October 15–December 7 open enrollment period because premiums, covered drugs and pharmacy networks can change. It cites 2027 figures including a $700 maximum deductible and a $2,400 out-of-pocket cap; beneficiaries should check official Medicare materials and the Plan Finder for their own coverage and costs.

Kiplinger’s Medicare Part D report urges beneficiaries to compare prescription drug plans during the October 15–December 7 open enrollment period, saying yearly changes to premiums, drug coverage and pharmacy networks can affect what enrollees pay in 2027. The report cites a $700 maximum deductible and a $2,400 out-of-pocket cap for 2027, figures that readers should verify against official Medicare information when choosing coverage.

Part D coverage is sold by private insurers under federal rules. Insurers set plan premiums, covered-drug lists, cost tiers and pharmacy networks. Kiplinger says plans available in the same area can have different costs for the same prescriptions, so a low monthly premium alone does not show which option may cost less over a year.

The report recommends entering each medication, dosage and preferred pharmacy into the Medicare Plan Finder. It advises comparing plans by estimated drug and premium costs, which can account for premiums, deductibles and copayments based on the information entered. Results depend on the accuracy of that information and the plans available in a beneficiary’s area.

Kiplinger says formularies, drug tiers and preferred pharmacy arrangements can change annually. A prescription may be covered at a different cost tier, and using a pharmacy outside a plan’s preferred network may cost more. The report also says spouses should compare their prescriptions separately: one plan may not suit both people, and choosing different plans can mean using different pharmacies.

At a glance
reportWhen: Published ahead of the October 15–Decem…
The developmentKiplinger published guidance on comparing Medicare Part D plans ahead of the 2027 plan year, citing annual plan changes and federal cost limits.

How Plan Choices Affect Drug Costs

For people who take regular prescriptions, plan design can shape costs throughout the year. A plan with a lower premium may have a deductible or drug copayments that make its total estimated annual cost higher for a particular medication list. Pharmacy networks matter too: the report says the price at a standard pharmacy can be substantially higher than at a preferred one, though the exact difference depends on the plan and prescription.

Comparing coverage is also relevant when a person starts a medication, changes dosage or finds that a current drug is now available as a generic. Those developments may change which plan offers the more suitable coverage. The report’s advice is to review the actual drugs and pharmacies used, rather than assume last year’s choice remains the best fit.

The out-of-pocket cap is a key part of the 2027 figures cited by Kiplinger. The report says covered Part D drug spending is capped at $2,400, after which copayments and coinsurance for covered drugs fall to zero for the remainder of the year. That limit does not mean every drug or expense is covered: the report specifically refers to covered Part D drugs, and plan terms still matter.

Annual Enrollment and Federal Changes

Medicare’s annual open enrollment period runs from October 15 through December 7, according to Kiplinger. The report presents this window as the time to review available coverage for the next plan year. It says that even when a beneficiary’s health and prescriptions have not changed, an insurer may revise its premium, formulary, deductible or pharmacy network.

The report also describes the Part D coverage gap, often called the donut hole, as eliminated effective January 1, 2025. It attributes the redesigned benefit to the Inflation Reduction Act and says the 2027 out-of-pocket cap is $300 higher than the 2026 cap of $2,100. Kiplinger lists the 2027 maximum deductible as $700, compared with $615 in 2026. These amounts are presented as 2027 figures in the report, not as an individual’s guaranteed costs.

Another option discussed is the Medicare Prescription Payment Plan. Kiplinger describes it as a voluntary, fee-free way to spread eligible prescription costs into monthly bills from the plan, rather than paying those costs at the pharmacy counter. The supplied report excerpt says enrollment is handled through the Part D plan sponsor, but does not give all program rules or billing details.

““lowest drug + premium cost””

— Kiplinger

Plan Details Still Need Checking

The report’s figures describe 2027 plan limits, but the supplied material does not include an official CMS notice or links to the underlying federal data. Beneficiaries should confirm the 2027 deductible, out-of-pocket limit and base premium through Medicare or CMS materials before relying on them. The excerpt lists a 2027 base beneficiary premium of $41.33, but does not explain how that benchmark applies to a particular plan’s monthly premium.

Individual costs remain uncertain until a beneficiary checks the specific plans, drugs, dosages and pharmacies available in their location. The report does not provide a complete list of the ten items promised by its headline; the supplied excerpt gives detail on seven, and its description of the payment plan ends mid-explanation. It therefore does not establish every rule, exception or billing step relevant to that program.

Compare Plans Before December 7

Beneficiaries can review their current coverage and compare available options through the Medicare Plan Finder during open enrollment. Entering current prescriptions, dosages and preferred pharmacies can produce estimates tailored to the information supplied. Enrollees should check each plan’s covered-drug list, cost tiers, deductible and pharmacy network before making a selection.

Open enrollment ends December 7. People considering the Medicare Prescription Payment Plan can contact their Part D plan sponsor for current eligibility and enrollment details. The report does not specify when 2027 plan information will be finalized in the Plan Finder, so users should rely on the official tool and Medicare guidance for current availability and terms.

Key Questions

When can I compare Medicare Part D plans for 2027?

Kiplinger identifies the annual open enrollment period as October 15 through December 7. Check Medicare’s official guidance for current dates and plan availability.

What is the reported Part D out-of-pocket cap for 2027?

Kiplinger cites a $2,400 cap for covered Part D drug spending in 2027. It says copayments and coinsurance for covered drugs fall to zero after reaching that limit. Confirm the figure and its application with official Medicare materials.

Should spouses enroll in the same Part D plan?

Not automatically. The report says spouses may take different medications and should compare plans using their own drug lists and dosages. Pharmacy preferences and networks may also affect whether separate plans are practical.

How does the Medicare Prescription Payment Plan work?

Kiplinger describes it as an optional, fee-free program that spreads prescription costs into monthly bills from a plan sponsor instead of payment at the pharmacy counter. Contact the sponsor for current terms and enrollment details.

Source: rss

This content is for general information only and is not financial, tax or legal advice. Consult a qualified professional for decisions about your money.
FALL

Fall Picks

As an affiliate, we earn on qualifying purchases.

You May Also Like

XFLT Proxy Vote: What This Shareholder Vote Is Really About

An upcoming shareholder vote for XFLT has sparked interest; this article explains what the vote is about, confirmed facts, and what remains unclear.

Nike’s turnaround ‘not enough’ to remain bullish on the stock, KeyBanc says

KeyBanc states Nike’s recent turnaround efforts are insufficient to justify a bullish outlook, signaling continued caution for investors.

The Mortgage Add-On First-Time Buyers Rarely Understand

Many first-time buyers overlook how mortgage add-ons can affect their finances; understanding these features is crucial to avoid costly surprises.

GoPro Announces Financing From Founder And CEO Nicholas Woodman

GoPro announces that its founder and CEO, Nicholas Woodman, has provided new financing to support company growth, according to a PR Newswire release.